What is Evommune 's proceeds from issuance of preferred stock?

Evommune (EVMN) reported proceeds from issuance of preferred stock of $2M in Q4 2025.

What does proceeds from issuance of preferred stock mean?

Cash received from issuing preferred stock — hybrid equity that provides fixed dividends without common stock dilution.

Evommune EVMN Proceeds from issuance of preferred stock

Proceeds from issuance of preferred stock at other companies

QuantumScape Corporation QS

$44.12M—

Evolution Metals & Technologies Corp. EMAT

$5.55M—

Maze Therapeutics, Inc. Common StockMAZE

$17.7M—

Peapack-Gladstone FinancialPGC

$30M—

Lightpath TechnologiesLPTH

$4.67M—

Lexicon PharmaceuticalsLXRX

$26.55M—

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's proceeds from issuance of preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's proceeds from issuance of preferred stock?: Evommune (EVMN) reported proceeds from issuance of preferred stock of $2M in Q4 2025.
What does proceeds from issuance of preferred stock mean?: Cash received from issuing preferred stock — hybrid equity that provides fixed dividends without common stock dilution.